These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29577707)

  • 1. [Research Progress and Forensic Application on the Pathogenesis of Coronary Artery Spasm].
    Que CX; Yu YJ; Chen H; Shi C; Xue AM
    Fa Yi Xue Za Zhi; 2018 Feb; 34(1):60-66. PubMed ID: 29577707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT1-mediated deacetylation of NF-κB inhibits the MLCK/MLC2 pathway and the expression of ET-1, thus alleviating the development of coronary artery spasm.
    Wu BW; Wu MS; Liu Y; Lu M; Guo JD; Meng YH; Zhou YH
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H458-H468. PubMed ID: 33095054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalities-from bench to bedside.
    Shimokawa H
    Eur Heart J; 2014 Dec; 35(45):3180-93. PubMed ID: 25354517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant endoplasmic reticulum stress mediates coronary artery spasm through regulating MLCK/MLC2 pathway.
    Xue A; Lin J; Que C; Yu Y; Tu C; Chen H; Liu B; Zhao X; Wang T; Ma K; Li L
    Exp Cell Res; 2018 Feb; 363(2):321-331. PubMed ID: 29378169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary spasm, a pathogenic trigger of vulnerable plaque rupture.
    Wang LX; Lü SZ; Zhang WJ; Song XT; Chen H; Zhang LJ
    Chin Med J (Engl); 2011 Dec; 124(23):4071-8. PubMed ID: 22340344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models.
    Shimokawa H
    Jpn Circ J; 2000 Jan; 64(1):1-12. PubMed ID: 10651199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated Myosin Light Chain 2 (p-MLC2) as a Molecular Marker of Antemortem Coronary Artery Spasm.
    Li L; Li Y; Lin J; Jiang J; He M; Sun D; Zhao Z; Shen Y; Xue A
    Med Sci Monit; 2016 Sep; 22():3316-27. PubMed ID: 27643564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary spasm: clinical features and pathogenesis.
    Yasue H; Kugiyama K
    Intern Med; 1997 Nov; 36(11):760-5. PubMed ID: 9392345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smooth muscle contraction bands in the media of coronary arteries: a postmortem marker of antemortem coronary spasm?
    Factor SM; Cho S
    J Am Coll Cardiol; 1985 Dec; 6(6):1329-37. PubMed ID: 4067112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Therapeutic Agents Targeting the Pathogenesis of Coronary Artery Spasm: A Mini Review.
    Zhao X; Tian J; Ye Z; Xu M; Song X; Huang R
    Curr Vasc Pharmacol; 2021; 19(4):347-358. PubMed ID: 32493195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of vascular failure in coronary artery spasm.
    Kawano H; Node K
    J Cardiol; 2011 Jan; 57(1):2-7. PubMed ID: 21067896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Upregulated Rho-kinase and increased phosphorylation of myosin-binding subunit of myosin phosphates are key players in a porcine coronary artery spasm model with interleukin-1beta].
    Guan QG; Zeng DY; Sun XZ; Miao ZL; Zhou XC; He XZ; Han FT; Cheng Y; Zhang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):50-3. PubMed ID: 16626550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of coronary spasm and the pathophysiological events in regional vascular hypercontraction.
    Tomoike H
    Jpn Circ J; 1985 Jan; 49(1):101-7. PubMed ID: 3968859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm.
    Kandabashi T; Shimokawa H; Miyata K; Kunihiro I; Eto Y; Morishige K; Matsumoto Y; Obara K; Nakayama K; Takahashi S; Takeshita A
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2209-14. PubMed ID: 14592852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery spasm and no spasmogens?
    Kalsner S
    Med Hypotheses; 1993 Mar; 40(3):186-95. PubMed ID: 8502199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the cellular mechanisms of vasospasm.
    Ganz P; Alexander RW
    Am J Cardiol; 1985 Sep; 56(9):11E-15E. PubMed ID: 3901723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence at autopsy of spasm in the distal right coronary artery in persons with coronary heart disease dying suddenly.
    Mortensen ES; Rognum TO; Straume B; Jørgensen L
    Cardiovasc Pathol; 2007; 16(6):336-43. PubMed ID: 18005872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery spasm and vascular biology. Cholinergic constriction.
    Sakurai I
    Acta Pathol Jpn; 1991 Dec; 41(12):865-73. PubMed ID: 1785345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and Functional Coronary Artery Abnormalities in Patients With Vasospastic Angina Pectoris.
    Ong P; Aziz A; Hansen HS; Prescott E; Athanasiadis A; Sechtem U
    Circ J; 2015; 79(7):1431-8. PubMed ID: 26084380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Biochemical Markers Associated with the Occurrence of Coronary Spasm.
    Li L; Jin YP; Xia SD; Feng C
    Biomed Res Int; 2019; 2019():4834202. PubMed ID: 31637257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.